TNF and bone fracture: This view is supported by clinical data indicating that high levels of inflammatory factors such as interleukin (IL)-6 and tumor necrosis factor (TNF)-α are associated with a higher risk of bone fracture, and overwhelming preclinical evidence indicating that these cytokines stimulate bone resorption while inhibiting bone formation 19–21.